Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases

American Journal of Pathology

Volumn 159, Issue 5, 2001, Pages 1785-1795

  Yamada, Mitsunori ^a   Sato, Toshiya ^a   Shimohata, Takayoshi ^a   Hayashi, Shintaro ^a   Igarashi, Shuichi ^a   Tsuji, Shoji ^a   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE; RIBONUCLEOPROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS INCLUSION BODY; COILED BODY; CONTROLLED STUDY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; FEMALE; HUMAN; HUMAN CELL; MACHADO JOSEPH DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; TRANSGENIC MOUSE;

EID: 0035149350     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63025-8     Document Type: Article

References (48)

1. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
2. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
3. Hereditary dentatorubral-pallidoluysian atrophy: Detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain
4. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
5. Suppression of aggregate formation and apoptosis by transglutaminase inhibitions in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
6. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: Triple-labeling immunofluorescent study
7. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
8. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
9. Formation of intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
10. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
11. Polyglutamine pathogenesis
12. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
13. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
14. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila
15. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo
16. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
17. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
18. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
19. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
20. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
21. 1130: Interfering with CREB-dependent transcription
22. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
23. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
24. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies
25. Structure and function in the nucleus
26. The PML nuclear bodies: Actors or extras?
27. Nuclear bodies: Multifaceted subdomains of the interchromatin space
28. Transgenic mice harboring a full-length human DRPLA gene with highly expanded CAG repeats exhibit severe disease phenotype
29. Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation
30. Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies
31. Fine structural organization of the interphase nucleus in some mammalian cells
32. The "accessory body" of Cajal in the neuronal nucleus. A light and electron microscopic approach
33. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion
34. Nuclear dots: Actors on many stages
35. PML and COP1-two proteins with much in common
36. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
37. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
38. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/ SUMO-1
39. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
40. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
41. CREB-binding protein sequestration by expanded polyglutamine Hum Mol Genet
42. c-Jun and p53 activity is modulated by SUMO-1 modification
43. In vitro assembly of coiled bodies in Xenopus egg extract
44. Mutational analysis of p80 coilin indicates a functional interaction between coiled bodies and the nucleolus
45. Structure, expression and chromosomal localization of human p80-coilin gene
46. Coiled bodies and U2 snRNA genes adjacent to coiled bodies are enriched in factors required for snRNA transcription
47. The coiled body
48. In vivo analysis of Cajal body movement, separation, and joining in live human cells